Effects of glucocorticoids on fetal and neonatal lung development.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 15606220)

Published in Treat Respir Med on January 01, 2004

Authors

David G Grier1, Henry L Halliday

Author Affiliations

1: Department of Child Health, Queen's University Belfast, Northern Ireland, UK. grier@doctors.org.uk

Articles citing this

Glucocorticoid receptor-dependent gene regulatory networks. PLoS Genet (2005) 2.19

The Hsp90 cochaperone p23 is essential for perinatal survival. Mol Cell Biol (2006) 1.28

Perinatal stress and early life programming of lung structure and function. Biol Psychol (2010) 1.05

Control of steroid receptor dynamics and function by genomic actions of the cochaperones p23 and Bag-1L. Nucl Recept Signal (2014) 0.89

Expression of genes related to the hypothalamic-pituitary-adrenal axis in murine fetal lungs in late gestation. Reprod Biol Endocrinol (2010) 0.85

Glucocorticoid regulation of human pulmonary surfactant protein-B (SP-B) mRNA stability is independent of activated glucocorticoid receptor. Am J Physiol Lung Cell Mol Physiol (2011) 0.81

Decline in effectiveness of antenatal corticosteroids with time to birth: real or artefact? BMJ (2007) 0.80

Lipopolysaccharide-induced injury is more pronounced in fetal transgenic ErbB4-deleted lungs. Am J Physiol Lung Cell Mol Physiol (2011) 0.80

Intraventricular hemorrhage in neonates born before 32 weeks of gestation-retrospective analysis of risk factors. Childs Nerv Syst (2016) 0.80

Neonatal steroids induce a down-regulation of tenascin-C and elastin and cause a deceleration of the first phase and an acceleration of the second phase of lung alveolarization. Histochem Cell Biol (2013) 0.77

Administration of antenatal glucocorticoids and postnatal surfactant ameliorates respiratory distress syndrome-associated neonatal lethality in Erk3(-/-) mouse pups. Pediatr Res (2014) 0.77

Antenatal corticosteroids: a risk factor for the development of chronic disease. J Nutr Metab (2012) 0.77

What We Talk About When We Talk About Evolution. Cell Commun Insights (2015) 0.76

Effects of single course and multicourse betamethasone prior to birth in the prognosis of the preterm neonates: A randomized, double-blind placebo-control clinical trial study. J Res Med Sci (2014) 0.76

Surfactant metabolism and anti-oxidative capacity in hyperoxic neonatal rat lungs: effects of keratinocyte growth factor on gene expression in vivo. Histochem Cell Biol (2012) 0.76

Glucocorticoids accelerate maturation of the heme pathway in fetal liver through effects on transcription and DNA methylation. Epigenetics (2016) 0.75

Sequences of a hairpin structure in the 3'-untranslated region mediate regulation of human pulmonary surfactant protein B mRNA stability. Am J Physiol Lung Cell Mol Physiol (2012) 0.75

Full-term-pregnancy effects of antenatal betamethasone administration on short-term variation as assessed by computerized cardiotocography. J Prenat Med (2012) 0.75

Articles by these authors

Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med (2009) 7.94

Oxygen saturation and outcomes in preterm infants. N Engl J Med (2013) 4.96

Effects of hypothermia for perinatal asphyxia on childhood outcomes. N Engl J Med (2014) 2.41

Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics (2005) 2.05

European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants--2013 update. Neonatology (2013) 1.96

European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2010 update. Neonatology (2010) 1.72

Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology (2010) 1.71

Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia. N Engl J Med (2015) 1.68

Interventions to prevent hypothermia at birth in preterm and/or low birthweight infants. Cochrane Database Syst Rev (2010) 1.34

Metronidazole population pharmacokinetics in preterm neonates using dried blood-spot sampling. Pediatrics (2011) 1.18

Identification of diagnostic biomarkers for infection in premature neonates. Mol Cell Proteomics (2008) 1.18

HOX genes: seductive science, mysterious mechanisms. Ulster Med J (2006) 1.18

Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev (2014) 1.02

Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology (2010) 1.01

Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev (2014) 1.00

Peer-mentoring for first-time mothers from areas of socio-economic disadvantage: a qualitative study within a randomised controlled trial. BMC Health Serv Res (2008) 0.99

Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia. Pediatrics (2010) 0.98

Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology (2010) 0.96

Outcomes of Two Trials of Oxygen-Saturation Targets in Preterm Infants. N Engl J Med (2016) 0.95

General and respiratory health outcomes in adult survivors of bronchopulmonary dysplasia: a systematic review. Chest (2011) 0.95

Surfactant therapy: past, present and future. Early Hum Dev (2013) 0.91

Impaired lung function and health status in adult survivors of bronchopulmonary dysplasia. Eur Respir J (2013) 0.89

Oxygen saturation in immature babies: revisited with updated recommendations. Neonatology (2011) 0.89

Maternal betamethasone and chorioamnionitis induce different collagenases during lung maturation in fetal sheep. Neonatology (2008) 0.88

Airway remodelling in chronic lung disease of prematurity. Paediatr Respir Rev (2002) 0.87

Corticosteroids in the prevention and management of bronchopulmonary dysplasia. Semin Neonatol (2003) 0.86

European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2016 Update. Neonatology (2016) 0.85

Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels: implications for antenatal origins of chronic lung disease. Am J Obstet Gynecol (2003) 0.82

Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev (2012) 0.82

Quantification of Hox and surfactant protein-B transcription during murine lung development. Neonatology (2009) 0.82

The Neonatal European Study of Inhaled Steroids (NEUROSIS): an eu-funded international randomised controlled trial in preterm infants. Neonatology (2009) 0.82

Neurodevelopmental and respiratory follow-up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics (2006) 0.81

Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev (2012) 0.81

Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Cochrane Database Syst Rev (2012) 0.81

Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use. Drugs (2005) 0.80

Better neonatal outcomes: oxygen, surfactant and drug delivery. Preface. Neonatology (2013) 0.79

Influence of maternal diabetes mellitus on fetal iron status. Arch Dis Child Fetal Neonatal Ed (2006) 0.78

A unique story in neonatal research: the development of a porcine surfactant. Neonatology (2015) 0.78

Postnatal steroids: the way forward. Arch Dis Child Fetal Neonatal Ed (2011) 0.77

Surfactant therapy for neonatal respiratory distress syndrome in 2013. J Matern Fetal Neonatal Med (2013) 0.76

Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev (2015) 0.76

Modeling and remodeling of the lung in neonatal chronic lung disease: implications for therapy. Treat Respir Med (2005) 0.76

Lucinactant versus poractant-alpha in premature lambs. Pediatrics (2006) 0.75

More about surfactant, oxygen, caffeine and chronic lung disease. Neonatology (2014) 0.75

Prophylactic ranitidine treatment in critically ill children--a population pharmacokinetic study. Br J Clin Pharmacol (2013) 0.75

Population pharmacokinetic model of canrenone after intravenous administration of potassium canrenoate to paediatric patients. Br J Clin Pharmacol (2012) 0.75

Does intrauterine growth restriction affect quality of life in adulthood? Arch Dis Child (2007) 0.75

Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants. Cochrane Database Syst Rev (2017) 0.75

Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev (2017) 0.75

Global neonatal mortality and hypothermia for perinatal asphyxia. Preface. Neonatology (2010) 0.75

Editorial note: sources of neonatal medicine. Neonatology (2008) 0.75

Sharing Progress in Neonatal (SPIN) Brain, Gut, Heart, and Lung. Neonatology (2017) 0.75

Potassium canrenoate treatment in paediatric patients: a population pharmacokinetic study using novel dried blood spot sampling. J Hypertens (2013) 0.75

Bo Sun and the Development of Neonatology in China. Neonatology (2017) 0.75

Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev (2017) 0.75

Preface. Neonatology. Neonatology (2009) 0.75

Neonatology. Preface. Neonatology (2008) 0.75

Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev (2017) 0.75

Executive functioning deficits in young adult survivors of bronchopulmonary dysplasia. Disabil Rehabil (2015) 0.75

Mikko Hallman --a major translator of basic science into neonatal medicine. Neonatology (2011) 0.75

Update on Postnatal Steroids. Neonatology (2017) 0.75

Ola Didrik Saugstad--an oxygen radical. Neonatology (2008) 0.75

Extremely low-dose dexamethasone to facilitate extubation in mechanically ventilated preterm babies. Neonatology (2011) 0.75

30 years of surfactant research - from basic science to new clinical treatments for the preterm infant. Neonatology (2015) 0.75

Sharing Progress in Neonatal (SPIN) Lung and Brain. Neonatology (2016) 0.75

Tore Curstedt - the basic science creator of porcine surfactant. Neonatology (2014) 0.75